| Filed On | Filing |
|---|---|
| 13 Oct 2026 |
8-K/A: Completion of Acquisition or Disposition of Assets
On July 3, 2026, certain subsidiaries of Clarivate Plc (“Clarivate”) entered into a Stock and Asset Purchase Agreement (the “Purchase Agreement”) with an affiliate of Altaris, LLC (the “Buyer”), pursuant to which, among other things, Cla... |
| 08 Oct 2026 |
Form 4: Levy Henry, President, LS&H
Gave up 263,576 shares to cover exercise price or tax ($387K) |
| 06 Oct 2026 |
8-K: Completion of Acquisition or Disposition of Assets; Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers +1 more
Transaction sharpens strategic focus on leading Academia & Government and Intellectual Property segments |
| 02 Oct 2026 |
Form 4: Cornick Kenneth L., Director
Received 17,215 shares as a grant or award ($28.7K) · Gave up 3,444 shares to cover exercise price or tax ($5.75K) |
| 02 Oct 2026 |
Form 4: Bomba Jane L Okun, Director
Received 17,215 shares as a grant or award ($28.7K) · Gave up 181 shares to cover exercise price or tax ($302) |
| 02 Oct 2026 |
Form 4: Snyder Andrew Miles, Director
Received 30,688 shares as a grant or award ($51.2K) · Gave up 1,012 shares to cover exercise price or tax ($1.69K) |
| 24 Sep 2026 |
8-K: Other Events
LONDON, September 24, 2026: Clarivate Plc (NYSE: CLVT) ("Clarivate"), a leading global provider of transformative intelligence, today announced the expiration and final results of its previously announced cash tender offer (the "Offer") ... |
| 23 Sep 2026 |
8-K: Other Events
LONDON, September 23, 2026: Clarivate Plc (NYSE: CLVT) ("Clarivate"), a leading global provider of transformative intelligence, today announced the Reference Yield and Total Consideration (as set forth in the table below) to be paid in c... |
| 17 Sep 2026 |
8-K: Other Events
LONDON, September 17, 2026: Clarivate Plc (NYSE: CLVT) ("Clarivate"), a leading global provider of transformative intelligence, today announced that its wholly-owned subsidiary, Clarivate Science Holdings Corporation (the “Company”), has... |
| 18 Aug 2026 |
Form 4: Lisowski Matthew J., Senior VP, CAO
Received 67,357 shares as a grant or award |
| 18 Aug 2026 |
Form 4: Easton Michael M, Executive Vice President/CFO
Received 194,300 shares as a grant or award |
| 17 Aug 2026 |
Form 4: Shem Tov Matitiahu S., Director
Gave up 47,633 shares to cover exercise price or tax ($93.4K) |
| 14 Aug 2026 |
Form 3: Lisowski Matthew J., Senior VP, CAO
Holds 79,898 shares of Ordinary Shares |
| 10 Aug 2026 |
Form 4: Cornick Kenneth L., Director
Bought 650,000 shares ($1.21M) · Bought 250,000 shares ($463K) |
| 05 Aug 2026 |
Form 4: Snyder Andrew Miles, Director
Sold 2,489,618 shares ($4.83M) |
| 03 Aug 2026 | 144 |
| 29 Jul 2026 | 8-K: Departure/Election of Directors or Officers; Compensation; Regulation FD Disclosure |
| 29 Jul 2026 | 10-Q |
| 29 Jul 2026 | 8-K: Results of Operations and Financial Condition; Regulation FD Disclosure |
| 06 Jul 2026 | 8-K: Entry into a Material Definitive Agreement; Departure/Election of Directors or Officers; Compensation |
Loading...
